New research from academia
“this research could pave the way for techniques to identify brain cancer earlier and allow for more-effective treatment”
Read the entire article from The Ohio State University here.
A new plasmonic sensor developed by researchers at the University of Illinois at Urbana-Champaign will serve as a reliable early detection of biomarkers for many forms of cancer and eventually other diseases.
Research from University of Illinois
“…instead of needing a vile of blood for a test, a simple finger prick will do.”
For now, detection methods for cancer biomarkers are being implemented in high-risk patients, especially cancer patients in remission. They take time, specialized equipment, and are labor-intensive.
In the future, however, because of the portability and inexpensive nature of this method, it can be more easily administered to any patient at routine check-ups. This would allow those with an elevated concentration of CEA to be treated even before cancer cells spread in the body.
Read the full article at the University of Illinois Engineering site.
A test that measures the levels of five chemicals in the breath has shown promising results for the detection of cancers of the oesophagus and stomach in a large patient trial presented at the European Cancer Congress 2017. The new research aimed to test whether this “chemical signature” that seemed to typify cancer could be the basis of a diagnostic test.
“A breath test could be used as a non-invasive, first-line test to reduce the number of unnecessary endoscopies. In the longer term this could also mean earlier diagnosis and treatment, and better survival.”
– Dr Sheraz Markar, NIHR Clinical Trials Fellow from Imperial College London
The trial was based on the results of previous research that suggested differences in the levels of specific chemicals (butyric, pentanoic and hexanoic acids, butanal, and decanal) between patients with stomach or oesophageal cancer and patients with upper gastrointestinal symptoms without cancer.
The results showed that the test was 85% accurate overall, with a sensitivity of 80% and a specificity of 81%. This means that not only was the breath test good at picking up those who had cancer (sensitivity), it was also good at correctly identifying who did not have cancer (specificity).
Find out more about this test at http://bit.ly/2juaaGQ
Recent Comments